04 Oct 2023 --- Swiss biotech company Evolva and Lehvoss Group Nutritional Division have signed a distribution agreement involving the use of Veri-te Resveratrol in dietary supplements. The deal is expected to generate roughly CHF 1.5 million (US$1.6 million) in sales by its conclusion in 2025.
